Federal Research:
Small Business Innovation Research Shows Success but Can Be Strengthened
RCED-92-37: Published: Mar 30, 1992. Publicly Released: Mar 30, 1992.
Additional Materials:
- Full Report:
Contact:
(202) 512-6082
contact@gao.gov
Office of Public Affairs
(202) 512-4800
youngc1@gao.gov
Pursuant to a legislative requirement, GAO reviewed the aggregate commercial trends in Phase III of the Small Business Innovation Research (SBIR) Program.
GAO found that: (1) Congress authorized the SBIR Program to strengthen the role of small, innovative companies in research and development; (2) Phase III involves the use of nonfederal funds for commercial application of technology or non-SBIR federal funds for government contracts for government application; (3) as of July 1991, the SBIR Program had generated about $1.1 billion in Phase III sales and additional funding for technical development; (4) according to a survey of 1,457 Phase II projects, 934 projects have remained active while 518 have been discontinued; (5) commercialization trends vary by agency; (6) reasons for such differences in commercialization trends include the wide variation in markets for SBIR projects or processes and in links between projects and agency missions; (7) issues that affect Phase III activity include the extent of the Department of Defense's (DOD) commitment to the goal of increasing private-sector commercialization, inconsistent procurement practices in requiring competition for SBIR projects entering phase III, and whether the company or the agency that funded the work should perform additional work after phase II if the agency wishes to continue work on the technology; and (8) the Small Business Administration (SBA) has initiated a study of the operating attributes of firms with multiple Phase II awards, since such companies have lower sales and require additional funding.
Matters for Congressional Consideration
Status: Closed - Implemented
Comments: The Small Business Innovation Development Amendment Act was passed on October 8, 1992.
Matter: To further the goal of increasing private-sector commercialization, Congress may wish to consider whether DOD should place greater emphasis on commercialization through such means as identifying and selecting dual-use technologies for SBIR awards.
Status: Closed - Implemented
Comments: The Small Business Innovation Development Amendment Act was passed on October 8, 1992.
Matter: To eliminate inconsistent agency practices in requiring competition for federal, non-SBIR-funded follow-on contracts, Congress may wish to consider clarifying whether Phase III activity must comply with the Competition in Contracting Act's (CICA) competitive procedures or whether the competition in the earlier phases of the program satisfies CICA requirements.
Status: Closed - Implemented
Comments: The Small Business Innovation Development Amendment Act was passed October 8, 1992.
Matter: To avoid misunderstandings between companies and federal agencies, Congress may wish to consider requiring the Administrator, SBA, to issue a policy directive for agencies that are planning to work on a company's SBIR technology after the end of SBIR funding. Such a directive would clarify the circumstances under which it may be appropriate for an agency to continue working with a company through a follow-on, non-SBIR-funded contract.
Explore the full database of GAO's Open Recommendations
»
Feb 24, 2021
-
Science & Tech Spotlight:
Vaccine SafetyGAO-21-342SP: Published: Feb 24, 2021. Publicly Released: Feb 24, 2021.
Feb 18, 2021
-
Technology Assessment Design HandbookGAO-21-347G: Published: Feb 18, 2021. Publicly Released: Feb 18, 2021.
Feb 3, 2021
-
Federal Research Grants:
OMB Should Take Steps to Establish the Research Policy BoardGAO-21-232R: Published: Feb 3, 2021. Publicly Released: Feb 3, 2021.
Feb 1, 2021
-
Department of Energy:
Improved Performance Planning Could Strengthen Technology TransferGAO-21-202: Published: Feb 1, 2021. Publicly Released: Feb 1, 2021.
Jan 29, 2021
-
Small Business Innovation Research:
Three Agencies Made Awards to Businesses Majority-Owned by Investment Companies and FundsGAO-21-223R: Published: Jan 29, 2021. Publicly Released: Jan 29, 2021.
Dec 21, 2020
-
Science & Tech Spotlight:
Tracing the Source of Chemical WeaponsGAO-21-271SP: Published: Dec 21, 2020. Publicly Released: Dec 21, 2020.
Dec 17, 2020
-
Federal Research:
Agencies Need to Enhance Policies to Address Foreign InfluenceGAO-21-130: Published: Dec 17, 2020. Publicly Released: Dec 17, 2020.
Dec 7, 2020
-
Science & Tech Spotlight:
Air Quality SensorsGAO-21-189SP: Published: Dec 7, 2020. Publicly Released: Dec 7, 2020.
Nov 30, 2020
-
Artificial Intelligence in Health Care:
Benefits and Challenges of Technologies to Augment Patient CareGAO-21-7SP: Published: Nov 30, 2020. Publicly Released: Nov 30, 2020.
Nov 20, 2020
-
Biomedical Research:
NIH Should Publicly Report More Information about the Licensing of Its Intellectual PropertyGAO-21-52: Published: Oct 22, 2020. Publicly Released: Nov 20, 2020.
Looking for more? Browse all our products here